Parkinson's Disease Research

Parkinson's disease (PD) is a degenerative disease of the central nervous system that often impairs motor skills, speech, and other functions. Symptoms of the disease include resting tremor, bradykinesia and rigidity. The primary symptoms are the result of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Symptoms of the disease appear once 50-80% of dopamine neurons have died. Parkinson's disease is both chronic and progressive.

Parkinson's Disease Research Products Targets

Products for Parkinson's Disease Research - Page 22

  1. Cat.No. Product Name Information/Activity
  2. BCC6200 A 844606 861119-08-6 A 844606 chemical structure
  3. BCC7827 AR-R 17779 hydrochloride 178419-42-6 AR-R 17779 hydrochloride chemical structure
  4. BCC7948 GTS 21 dihydrochloride GTS-21 dihydrochloride is a selective α7 nicotinic acetylcholine receptor agonist, has recently been established as a promising treatment for inflammation. GTS 21 dihydrochloride chemical structure
  5. BCC5972 PHA 543613 hydrochloride 478149-53-0 PHA 543613 hydrochloride chemical structure
  6. BCC7574 PHA 568487 527680-57-5 PHA 568487 chemical structure
  7. BCC7700 S 24795 304679-75-2 S 24795 chemical structure
  8. BCC6182 SEN 12333 874450-44-9 SEN 12333 chemical structure
  9. BCC7394 TC 1698 dihydrochloride 787587-06-8 TC 1698 dihydrochloride chemical structure
  10. BCC7264 α-Bungarotoxin 11032-79-4 α-Bungarotoxin chemical structure
  11. BCC1047 COG 133 ApoE peptide fragment; <span class='symbol'>&#945;</span>7 nAChR antagonist COG 133 chemical structure

Items 211 to 220 of 752 total